Abstract: A positioning or timing receiver, for receiving pseudo-noise encoded signals includes mask mixers in the main signal paths, prior to accumulators. The mask mixers are fed with mask signals having a period equal to the period of the pseudo-noise code, provided by a mask generator. The mask generator and mixers provide an extra level of functionality in the receiver, through which a large number of uses can be made. For example, without modifying a code signal mixed into the main signal path, the mask mixers allow dynamic adaptability from a wide correlator to a narrow correlator by simple control of the mask generator. Many different discrimination patterns can be obtained. By changing the mask signals and examining correlator outputs, it is possible to detect whether a signal being tracked contains a multipath component. The receiver also includes a switch, whereby two correlators may be fed with signals from the in-phase main signal path.

Abstract: An apparatus includes a plurality of AND gates each to receive as input a bit of a first binary vector and a corresponding bit of a second binary vector, where the length of the first binary vector is not greater than the length of the second binary vector. The apparatus also includes a multiple input XOR gate to calculate in a single cycle a scalar product of the first binary vector and the second binary vector by performing an exclusive OR operation on the output of each of the AND gates.

Abstract: The invention relates to a process for treating lameness with an osseous, articular or osteoarticular component, comprising the administration, to a human or to an animal not suffering from arthritis or from fractures, of an effective amount of a bisphosphonic acid derivative of formula: 1

Abstract: The invention relates to a process for treating lameness with an osseous, articular or osteoarticular component, comprising the administration, to a human or to an animal not suffering from arthritis or from fractures, of an effective amount of a bisphosphonic acid derivative of formula: in which: R1 represents a hydrogen atom, a halogen atom, a hydroxyl, an amino, a mono(C1-C4)alkylamino or a di(C1-C4) alkylamino; R2 represents a halogen atom, a linear alkyl comprising from 1 to 5 carbon atoms which is unsubstituted or substituted with a group chosen from a chlorine atom, a hydroxyl, an amino, a mono (C1-C4) alkylamino or a di(C1-C4) alkylamino; a (C3-C7) cycloalkylamino, or R2 represents a phenoxy, a phenyl, a thiol, a phenylthio, a chlorophenylthio, a pyridyl, a pyridyl-methyl, a 1-pyridyl-1-hydroxymethyl, an imidazolyl-methyl or a 4-thiomorpholinyl, of one of its pharmaceutically acceptable salts or of one of its hydrates.

Abstract: The present invention relates to a process for increasing the egg production and strengthening the eggshells of poultry, which comprises the administration to the animal of at least one bisphosphonic compound chosen from a bisphosphonic acid, a physiologically acceptable salt thereof, hydrates thereof and mixtures thereof.

Abstract: The present invention relates to a stable, nondetergent composition based on fatty acids, in microemulsion form, for administration to humans or animals, comprising: from 5 to 30% by weight of one or more fatty acids with a free carboxylic acid function, as active ingredient; from 5 to 35% by weight of one or more surfactants; from 5 to 30% by weight of one or more C1-C12 alcohols, as cosurfactant; from 5 to 35% by weight of one or more water-soluble compounds with a carbonyl or hydroxyl function; and from 0 to 35% by weight of one or more water-immiscible compounds; the said composition having a pH of less than 6.5.

Abstract: The present invention relates to the use of an active substance selected from the group consisting of tiludronic acid, one of its pharmaceutically acceptable salts, one of its hydrates and mixtures thereof, in the preparation of a medicinal product for preventing and treating osteoporosis in poultry.

Abstract: The invention relates to a process for treating lameness with an osseous, articular or osteoarticular component, comprising the administration, to a human or to an animal not suffering from arthritis or from fractures, of an effective amount of a bisphosphonic acid derivative of formula: in which: R1 represents a hydrogen atom, a halogen atom, a hydroxyl, an amino, a mono(C1-C4)alkylamino or a di(C1-C4)alkylamino; R2 represents a halogen atom, a linear alkyl comprising from 1 to 5 carbon atoms which is unsubstituted or substituted with a group chosen from a chlorine atom, a hydroxyl, an amino, a mono(C1-C4)alkylamino or a di(C1-C4)alkylamino; a (C3-C7) cycloalkylamino, or R2 represents a phenoxy, a phenyl, a thiol, a phenylthio, a chlorophenylthio, a pyridyl, a pyridyl-methyl, a 1-pyridyl-1-hydroxymethyl, an imidazolyl-methyl or a 4-thiomorpholinyl, of one of its pharmaceutically acceptable salts or of one of its hydrates.

Abstract: This invention relates to a method of selecting nonpathogenic bacterial strains capable of binding to the receptor sites for tissue adhesion of pathogenic bacterial strains, comprising the steps consisting in: a) bringing the said receptors into contact in vitro with a bacterial strain to be tested; b) adding an antibody directed against the said receptors, the said antibody being optionally labelled in a detectable manner; c) in the case where the said antibody is itself not labelled in a detectable manner, adding an agent for detecting the antibody; d) detecting the presence of the complex formed between the said antibody and the said receptors.

Abstract: A process for stabilizing and preserving harvested vegetables in an acidic environment within a silo. The acidity results from the significant degradation of starch, complex carbohydrates and fermentable carbohydrates. A mixture of bacteria capable of degrading the complex carbohydrates, bacteria capable of causing lactic fermentation of fermentable sugars, and enzymes having a complementary action capable of degrading the complex carbohydrates into fermentable sugars which may be used by the bacteria is used in the process. The bacteria composition may comprise a mixture of fungic amylases, amylases of bacterial origin, amyloglucosidase, and hemicellulase.